USFDA issues Form 483 with 2 observations to Alembic, Gujarat

"None of the observations are related to data integrity and management believes that they are addressable," it said.

533
USFDA Form 483
USFDA Form 483

Last Updated on October 9, 2024 by The Health Master

Ahmedabad: Alembic Pharmaceuticals Ltd on Friday said the US health regulator has issued a Form-483 with two minor procedural observations following inspection of its injectable and ophthalmic facility (F-3) located at Karkhadi in Gujarat.

The US Food and Drug Administration (USFDA) had inspected the plant from March 16-24, 2023, the company said in a regulatory filing.

As per US Food and Drug Administration (USFDA), Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.

“None of the observations are related to data integrity and management believes that they are addressable,” it said.

The company is preparing the response to the observations, which will be submitted to the USFDA within the stipulated period, Alembic added.

In a separate filing, the company said the Brazilian Health Regulatory Agency (ANVISA) has completed a good manufacturing practice audit at API-III facility at Karakhadi without any observations for its 56 active pharmaceutical ingredients.

The inspection was conducted from March 20-24, 2023, it added.

USFDA issues Form 483 with 3 observations to Bliss GVS Pharma, Maharashtra

USFDA issues Form 483 with one observation to Torrent, Gujarat

USFDA issues Form 483 with 4 observations to Indoco Remedies, Goa

USFDA issues Form 483 with 8 observations to Cipla for Pithampur facility

USFDA issues Form 483 with 2 observations to Laurus Labs for Visakhapatnam facility

USFDA issues 2 observations to Natco Pharma for Vizag facility

USFDA gives approval for Calcipotriene and Betamethasone foam

West Bengal notice to Pharma Industry on bio-resource use

USFDA gives approval for Brexpiprazole tablets

Govt constitutes panel for PLI scheme for pharmaceuticals

USFDA gives approval for generic Rocuronium Bromide Injection

Difference: Disintegration and Dissolution test in pharma industry

USFDA gives approval for Prochlorperazine Maleate Tablets USP

How to prepare SOPs in the Pharma Industry

Difference between branded and generic medicines

Understanding DQ, IQ, PQ, and OQ in the Pharma Industry

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news